The expansion will add 10 KL of SPPS reactor capacity and establish six parallel cGMP manufacturing lines to support peptide ...
Dr. Reddy’s Laboratories announced that Brazil’s National Health Surveillance Agency (ANVISA) has granted marketing ...
The sectors recorded 19 funding rounds during the month, with funding rising 6.91 per cent year on year and falling 7.35 per ...
The agreement with Janssen Sciences Ireland enables commercialisation of the proposed Stelara biosimilar in Australia, Brazil ...
Under the existing agreement, injectable lenacapavir will be available at US$40 per person per year across 120 countries covered by Gilead’s voluntary licence.
Phatebo sources the comparator, investigational and ancillary medicines that pharmaceutical sponsors and clinical research organisations need to run their trials, and becomes HRV’s first finished form ...
The six-day programme, organised by FABA with academic and industry partners, covers medicinal chemistry, AI-based drug ...
Contract follows successful Process Development and scale-up of a new product, marking a key commercial milestone for ...
Three-member committee to assess whether existing safeguards against unethical marketing are effective and recommend changes ...
The certification follows inspections by Brazil’s ANVISA and Japan’s PMDA, supporting Hikal’s expansion across regulated ...
What gaps in India’s dermatology and skincare market led to the creation of Puresta, and how does the company plan to build a ...
Acquisition adds a 30,000 sqm pharmaceutical platform to Messe Muenchen India’s portfolio, connecting research, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results